Save your place

Sign in to WhoBought

Please try again later.

Jeremy Grantham's CVS Health Corp. (CVS) position

Yes: as of Q1 2026, Jeremy Grantham holds 635K shares of CVS worth $46M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$46M
Shares held
635K
% of portfolio
0.1%
Est. average buy price (i)
$76.32
est. since Q1 2021
Quarter-end price
$71.82

Estimated trade prices

Average price in quarters with purchases
$78.51
Average prices in quarters with sales
  • Q1 2026: $77.05 (86K shares sold)
  • Q4 2025: $78.87 (40K shares sold)
  • Q3 2025: $68.53 (91K shares sold)
  • Q2 2025: $65.57 (89K shares sold)
  • Q4 2024: $56.10 (119K shares sold)
  • Q1 2024: $76.39 (66K shares sold)
  • Q4 2023: $71.17 (56K shares sold)
  • Q1 2022: $105.05 (62K shares sold)
  • Q4 2021: $92.41 (81K shares sold)

CVS price vs Grantham's position

1Y 3Y 5Y MAX
Dates
$40$100$15020222023202420252026Added 18K shares (4.9%) · Q3 2021. Average closing price $83.76 · Price range $80.05–$87.4718KsharespurchasedSold 81K shares (21.2%) · Q4 2021. Average closing price $92.41 · Price range $83.15–$103.7081KsharessoldSold 62K shares (20.4%) · Q1 2022. Average closing price $105.05 · Price range $100.77–$110.8362KsharessoldAdded 84K shares (34.8%) · Q2 2022. Average closing price $97.60 · Price range $88.66–$106.6484KsharespurchasedAdded 47K shares (14.5%) · Q3 2022. Average closing price $98.99 · Price range $92.53–$106.4347KsharespurchasedAdded 159K shares (42.7%) · Q4 2022. Average closing price $96.49 · Price range $87.84–$103.79159KsharespurchasedAdded 199K shares (37.6%) · Q1 2023. Average closing price $83.85 · Price range $72.37–$92.91199KsharespurchasedAdded 71K shares (9.8%) · Q2 2023. Average closing price $71.15 · Price range $66.65–$77.7571KsharespurchasedAdded 37K shares (4.6%) · Q3 2023. Average closing price $70.86 · Price range $65.17–$76.4137KsharespurchasedSold 56K shares (6.6%) · Q4 2023. Average closing price $71.17 · Price range $66.29–$79.0056KsharessoldSold 66K shares (8.4%) · Q1 2024. Average closing price $76.39 · Price range $71.99–$81.4266KsharessoldAdded 173K shares (24.2%) · Q2 2024. Average closing price $62.55 · Price range $53.63–$79.56173KsharespurchasedAdded 5K shares (0.5%) · Q3 2024. Average closing price $58.34 · Price range $55.81–$63.185KsharespurchasedSold 119K shares (13.3%) · Q4 2024. Average closing price $56.10 · Price range $43.78–$67.46119KsharessoldAdded 166K shares (21.3%) · Q1 2025. Average closing price $59.84 · Price range $44.22–$68.64166KsharespurchasedSold 89K shares (9.5%) · Q2 2025. Average closing price $65.57 · Price range $60.04–$70.1889KsharessoldSold 91K shares (10.7%) · Q3 2025. Average closing price $68.53 · Price range $58.75–$76.5091KsharessoldSold 40K shares (5.2%) · Q4 2025. Average closing price $78.87 · Price range $75.00–$83.0440KsharessoldSold 86K shares (12.0%) · Q1 2026. Average closing price $77.05 · Price range $70.14–$83.8786Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$77.05
Price range · filing quarter
$70.14 – $83.87
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −86K −$6.6M −12.0% 635K May 14, 2026
Q4 2025 Reduced −40K −$3.1M −5.2% 721K Feb 17, 2026
Q3 2025 Reduced −91K −$6.3M −10.7% 761K Nov 13, 2025
Q2 2025 Reduced −89K −$5.8M −9.5% 852K Aug 13, 2025
Q1 2025 Added +166K +$9.9M +21.3% 941K May 14, 2025
Q4 2024 Reduced −119K −$6.6M −13.3% 776K Feb 13, 2025
Q3 2024 Added +5K +$265K +0.5% 894K Nov 13, 2024
Q2 2024 Added +173K +$11M +24.2% 890K Aug 13, 2024
Q1 2024 Reduced −66K −$5.0M −8.4% 717K May 14, 2024
Q4 2023 Reduced −56K −$4.0M −6.6% 782K Feb 13, 2024
Q3 2023 Added +37K +$2.6M +4.6% 838K Nov 13, 2023
Q2 2023 Added +71K +$5.1M +9.8% 801K Aug 14, 2023
Q1 2023 Added +199K +$17M +37.6% 730K May 12, 2023
Q4 2022 Added +159K +$15M +42.7% 530K Feb 13, 2023
Q3 2022 Added +47K +$4.7M +14.5% 372K Nov 10, 2022
Q2 2022 Added +84K +$8.2M +34.8% 325K Aug 12, 2022
Q1 2022 Reduced −62K −$6.5M −20.4% 241K May 13, 2022
Q4 2021 Reduced −81K −$7.5M −21.2% 303K Feb 11, 2022
Q3 2021 Added +18K +$1.5M +4.9% 384K Nov 12, 2021
Q2 2021 Added +51K +$4.2M +16.1% 366K Aug 12, 2021
Q1 2021 First covered – – – 315K May 13, 2021
Data through Q1 2026 · filed May 14, 2026
21 grouped rows from 21 quarters

More Grantham positions

Microsoft Corporation(MSFT)
$2.3B
5.8% of portfolio

Alphabet Inc.(GOOGL)
$1.9B
5.1% of portfolio

Johnson & Johnson(JNJ)
$1.8B
4.6% of portfolio

Apple Inc.(AAPL)
$1.8B
4.5% of portfolio

Meta Platforms, Inc.(META)
$1.7B
4.5% of portfolio

Lam Research Corporation(LRCX)
$1.4B
3.8% of portfolio

Common questions

Does Jeremy Grantham own CVS?

Yes. As of Q1 2026, Jeremy Grantham disclosed 635K shares of CVS, worth $46M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jeremy Grantham buy CVS?

Jeremy Grantham held CVS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jeremy Grantham sell CVS?

The quarter-by-quarter table above shows each sale and reduction Jeremy Grantham disclosed in CVS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of CVS does Jeremy Grantham own?

Jeremy Grantham disclosed 635K shares of CVS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jeremy Grantham pay for CVS?

Jeremy Grantham began building the CVS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.